Ontology highlight
ABSTRACT: Background
Thrombolytic therapy with intravenous alteplase within 4.5 hours of ischemic stroke onset increases the overall likelihood of an excellent outcome (no, or nondisabling, symptoms). Any improvement in functional outcome distribution has value, and herein we provide an assessment of the effect of alteplase on the distribution of the functional level by treatment delay, age, and stroke severity.Methods
Prespecified pooled analysis of 6756 patients from 9 randomized trials comparing alteplase versus placebo/open control. Ordinal logistic regression models assessed treatment differences after adjustment for treatment delay, age, stroke severity, and relevant interaction term(s).Results
Treatment with alteplase was beneficial for a delay in treatment extending t
SUBMITTER: Lees KR
PROVIDER: S-EPMC5024752 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature